The Drug Regulatory Authority of Pakistan (DRAP) had the privilege of hosting the participants of the 44th Mid-Career Management Course (MCMC) from NIMC Islamabad. The delegation was led by senior instructors Mr. Muhammad Imran and Mr. Jameel Ahmad Sheikh. CEO DRAP, Dr. Obaidullah, warmly welcomed the participants and shared insights on DRAP’s recent initiatives aimed at ensuring the availability of safe, effective, and quality therapeutic goods across Pakistan. The interactive session highlight

The Drug Regulatory Authority of Pakistan (DRAP) is taking a major step towards strengthening the nation's pharmaceutical industry. 🇵🇰 On September 1, 2025, we hosted a consultative meeting with key stakeholders from the pharmaceutical industry and allied sectors to discuss a roadmap for the Promotion of Basic & Semi-Basic Drug Manufacturing in Pakistan. A key objective is to reduce our heavy reliance on imported APIs (Active Pharmaceutical Ingredients) and intermediates. This initiative will

Pakistan Steps Forward in Indigenous Vaccine Manufacturing 💉🇵🇰 Drug Regulatory Authority of Pakistan (DRAP) convened a Consultative Meeting on Vaccine Manufacturing & WHO Prequalified Products on 25th September 2025, chaired by the Honorable Federal Minister for National Health Services, Regulations & Coordination. The Minister emphasized the Government’s clear commitment to vaccine self-reliance, modernization of regulatory systems, and achieving the ambitious pharmaceutical export target. T

DRAP and CCP Sign MoU for Mutual Cooperation The Drug Regulatory Authority of Pakistan (DRAP) and the Competition Commission of Pakistan (CCP) have formally signed a Memorandum of Understanding (MoU) to strengthen institutional coordination for improved governance of the therapeutic goods sector. The MoU, signed by DRAP CEO Dr. Obaidullah and Mr. Salman Amin, Member CCP, lays the foundation for enhanced collaboration on matters related to deceptive marketing practices, mergers and acquisitions,